Bill Gates, co-chair of the Bill and Melinda Gates Foundation, says progress is ongoing in the clinical trial of the M72 tuberculosis vaccine, expressing optimism in its offering 70 per cent efficacy. Gates said this while responding to a News Agency of Nigeria (NAN) question during an interview session with selected journalists yesterday in Abuja....The post Bill Gates Optimistic Of Progress In TB Vaccine Clinical Trial first appeared on New Telegraph.The post Bill Gates Optimistic Of Progress In TB Vaccine Clinical Trial appeared first on New Telegraph.
Related Articles
Don't miss out on breaking stories and in-depth articles.